Picture Fairtec GmbH Worldwide Event Solutions 650x65px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5498 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 41 42 43 ... 53 54 55  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Mologen–SEVERAL: investment, 201207 capital increase €22m gross proceeds 2,589,819 shares €8.5/share 2012-07-10
Bayer–Horizon Discovery: Genesis technology, 201207– collab €na development of pre-clinical cell line models for oncology research using Genesis 2012-07-09
Boehringer–Harvard Univ: drug research, 201207– collab funding of serveral translational research projects at Harvard by BI 2012-07-09
Genkyotex–SEVERAL: investment, 201207 financing round Series C extension of CHF25m=$26m from all Series C investors 2012-07-09
KWS Saat–Two Blades Foundation: TAL Code technology, 201207– non-excl commercial license €na to KWS Saat AG commercial use in certain crop plants 2012-07-09
Medicyte–Reinnervate: cell research technology, 201207– collab €na product integration of upcyte + Alevtex Scaffold technologies 2012-07-09
Celtic Therapeutics–Cancer Research UK: antibody-drug conjugates, 201207– collab €na developm ADCs to treat cancer by ADC Therapeutics + CRT 2012-07-06
Sinphar Pharmaceutical–Medigene: EndoTAG-1, 201207– collab excl co-developm + commercialisation by SynCore Biotechnology in Asia, AUS + NZ 2012-07-06
Merck (DE)–MDxHealth: molecular companion diagnostics, 201207– collab expansion €na ww developm + commerc PredictMDx for Glioblastoma w cilengitide 2012-07-05
4SC–SEVERAL: investment, 201207 capital increase up to 8.4m new shares €12.6m €1.5/share 2012-07-04
AgraQuest–Bayer: investment, 201207–201208 acquisition $425m + milestones by Bayer CropScience 2012-07-03
Euroimmun–Taylor Wessing: legal services, 201207 advisor to Euroimmun with regard to acquisition of GMK (BR) by Euroimmun 2012-07-03
Ferring–Albireo: elobixibat, 201207– license ww excl Japan + some Asian countries for developm + commercialisation 2012-07-03
GMK (BR)–Euroimmun: investment, 201207 acquisition 100% €na by Euroimmun Medizinische Labordiagnostik AG 2012-07-03
NZ Labs–Eurofins: investment, 201207 acquisition of New Zealand Laboratory Services Ltd by Eurofins 2012-07-02
Procognia–Scienion: print/spotting technology, 201207 supply use sciFlexarrayer to produce Multi Pad GlycoScope lectin microarray 2012-07-02
genXpress–Anagnostics: molecular diagnostics, 201207– distribution of pharmacogenetics products by genXpress in Austria 2012-07-01
Paion–Germany (govt): grant, 201207–201412 KMU-Innovativ BMBF grant €700k for developm of thrombomodulin-mutants 2012-07-01
Re-Liver project–EU (govt): grant, 201207c– FP7 grant €4.2m for developm of biomimetic bioartificial liver 2012-07-01
Corimmun–JnJ: investment, 201206 acquisition €100m + milestones durch Janssen-Cilag GmbH 2012-06-28
Anagnostics–Kompass: molecular diagnostics, 201206– collab + license for SepsiTest sample prep kit to develop hybcell Pathogens DNA 2012-06-27
Kreatech–Oridis: pharmacogenomics, 201206– collab developm + commercialisation of DNA-FISH assays for oncology 2012-06-26
Courtagen–Scienion: print/spotting technology, 201206 supply use sciFlexarrayer S11 to produce QDx BioChips for Avantra Q400 Biomarker Workstation 2012-06-25
Intelligent Bio-Systems–Qiagen: investment, 2012 acquisition €na 2012-06-25
Qiagen–SAP: bioinformatics, 201206– collab application of SAP HANA platform for analysis of sequencing data 2012-06-25
NEU² project–Epomedics: MS drug RnD, 201206– collab Epomedics GmbH becomes project member 2012-06-22
Zedira–R-Biopharm: investment, 201206 existing investor is R-Biopharm AG 2012-06-22
Peqlab–Eppendorf: thermal cycler, 201206– license covering gradient technology for thermal cyclers to Peqlab 2012-06-21
NatLifE 2020 project–Germany (govt): grant, 201206– up to 9y funding from BMBF under Industrial Biotechnology Innovation Initiative 2012-06-18
Vela–Eppendorf: automated liquid handling, 201206 collab joint developm of Sentosa SX system based on epMotion system for Vela Diagnostics 2012-06-18
Synthes–JnJ: investment, 201206 acquisition $19.7b with CHF55.65 in cash + 1.717 JnJ shares for each Synthes share 2012-06-14
Topsfield Medical–High-Tech Gründerfonds: investment, 201206 seed financing from HTGF 2012-06-14
Bayer–Abbott & Cobb: seeds, 201206 acquisition €na of watermelon + melon seed business by Bayer CropScience 2012-06-12
GSK–Basilea: alitretinoin, 201206 acquisition £146m upfront + milestones of excl ww Toctino rights incl distribution agreements by Stiefel 2012-06-11
Enzymicals–BBG/Braun Group: investment, 201206 acquisition of stake in Enzymicals AG by Braun Beteiligungs GmbH 2012-06-08
Enzymicals–BRAIN: investment, 201206 investment of an additional sum by BRAIN AG 2012-06-08
Tecan–Reinnervate: cell culture system, 201206– collab co-marketing Alvetex Scaffold for 3D cell culture on Freedom EVO liquid handling workstation 2012-06-07
Merck (DE)–Dr. Reddy’s: biosimilar, 201206– collab co-development + manufacturing + commercialisation ww with exceptions Merck Serono 2012-06-06
Roche–Panasonic: blood glucose + lipid monitoring system, 201206– collab ww marketing by Roche manufactured by Panasonic Healthcare in Japan 2012-06-05
BRAIN–Germany (govt): grant, 201206– funding from BMBF for up to 9y as partner + coordinator of NatLifE 2020 alliance 2012-06-01
CryoTherapeutics–High-Tech Gründerfonds: investment, 201206–201303 financing round Series A totalling €3m incl investor HTGF in 1st closing June 2012 2012-06-01
CryoTherapeutics–SEVERAL: investment, 201206–201303 financing round Series A €3m NRW.Bank + HTGF + Rainer Christine + Getz Brothers + PVP 2012-06-01
Roche–AC Immune: therapeutic antibodies, 201206– license excl for anti-Tau program for Alzheimer’s disease to Genentech 2012-06-01
Bayer–Covance: clinical research services, 201205– supply strategic alliance incl phase 2–4 studies + central lab services for Bayer HealthCare 2012-05-30
AudioCure Pharma–High-Tech Gründerfonds: investment, 201205 seed financing from HTGF + business angel Dr Schumacher 2012-05-29
AudioCure Pharma–SEVERAL: investment, 201205 seed financing from High-Tech Gründersfonds + business angel Dr Schumacher 2012-05-29
Agilent–Prolab GmbH: mass spectrometer, –201205 collab co-development of integrated AACE LC/MS System for dried blood-spot analysis 2012-05-21
TU Munich–Nonlinear Dynamics: mass spectrometry s/w, 201205 supply existent use of Progenesis LC-MS s/w by Prof Küster 2012-05-21
EQT–Agilent: investment, 201205–201206 acquisition of Dako for $2.2b in cash on a debt-free basis 2012-05-17
Apeptico–SEVERAL: investment, 201205 financing round Series C €2m from BioScience Venture Group + V+ Fonds + private investors 2012-05-16
BioPlanta–Vita 34: investment, 201205 acquisition in shares with 380k new shares issued to BioPlanta owner + founder André Gerth 2012-05-16
Evotec–Agilent: mass spectrometer, 201205 supply 6460 Triple Quadrupole instrumentation to Hamburg facility 2012-05-16
Evotec–Agilent: mass spectrometer, 201205 supply multiple RapidFire High-throughput MS systems to Hamburg facility 2012-05-16
Cellzome–GSK: investment, 201205 acquisition remaining 80% for £61m ($99m) in cash 2012-05-15
Genome Diagnostics–Qiagen: PCR technology, 201205– distribution rights ww non-excl for Qiagen LongRange PCR kit together with SBTexcellerator reagents 2012-05-15
Ono Pharmaceutical–Coral BioNet: Affilin therapeutics, 201205– collab discovery + developm Affilin molecules against Ono targets with Scil Proteins 2012-05-15
T-Cell Europe–High-Tech Gründerfonds: investment, 201205 1st financing round totalling €1.45m incl HTGF 2012-05-15
T-Cell Europe–SEVERAL: investment, 201205 1st financing round €1.45m from HTGF + Constantin Bastian Leander Venture Capital + ILB 2012-05-15
Algiax Pharmaceuticals–High-Tech Gründerfonds: investment, 201205 financing round totalling €4.3m incl HTGF + private investors + KfW 2012-05-14
Algiax Pharmaceuticals–SEVERAL: investment, 201205 financing round €4.3m from HTGF + private investors + KfW 2012-05-14
Waters–Biocrates: AbsoluteIDQ Kits, 201205– collab Waters Xevo TQ MS editions of established AbsoluteIDQ p180 + p150 kits 2012-05-14
Fresenius–SEVERAL: investment, 201205 capital increase €1b placement of 13.8m new ordinary shares €73.5/share 2012-05-11
Baliopharm–Apo GbR: therapeutic antibody, 201205– ww excl license for bi-specific therapeutic antibody Novotarg 2012-05-09
Evotec–4-Antibody: antibody drug discovery, 201205– collab integration of output from Rectrocyte Display technology into Ab drug discovery services 2012-05-09
Sophia Genetics–SEVERAL: investment, 201205 seed funding CHF840k from private investors 2012-05-08
Intercell–Bellevue: credit, 201205– secured 6-year loan €20m with variable interest rate >=10.9% + sales royalties from BB Biotech 2012-05-07
Intercell–Bellevue: investment, 201205 acquisition €5m 1.962m shares €2.55/share as part of private placement w institutional investors 2012-05-07
AmniSure–Qiagen: investment, 201205 acquisition €na 2012-05-03
United States (govt)–Evotec: compound management, 201205– supply compound management services €7.7m for 5y to US EPA by Evotec San Francisco 2012-05-03
Mondobiotech–BioPharma Invest: investment, 201205 existent BioPharma Invest AG is main shareholder 2012-05-02
Novaliq–Hopp Group: investment, 201205 financing round €3.9m from Dievini Hopp BioTech Holding GmbH & Co KG 2012-05-02
Valeant–Gentium: defibrotide, 201205– distribution excl for 10 years in Central + Eastern European countries by PharmSwiss SA 2012-05-02
Abionic–SEVERAL: investment, 201205 financing round Series A CHF3.5m from local VCs + business angels 2012-05-01
Bayer–Two Blades Foundation: TAL Code technology, 201205– non-excl commercial license €na to Bayer CropScience commercial use in certain crop plants 2012-05-01
BF Holding–MC Services: public relations, 201205– service public + investor relations for MagForce AG 2012-05-01
Roche–Dako: molecular companion diagnostics, 201205– collab regulatory submission HercepTest + HER2 FISH pharmDx for trastuzumab-DM1 Genentech 2012-05-01
Two Blades Foundation–Univ Halle: TAL Code technology, 201205 excl license for commercial use in plants existent 2012-05-01
Cardinal Health–Qiagen: molecular diagnostics, 201204– distribution of Qiagen systems + kits to smaller + mid-sized US hospitals by Cardinal Health 2012-04-30
Gen-Probe–Hologic: investment, 201204–201208 acquisition $3.8b in cash $82.75/share 2012-04-30
Quotient Bioresearch–Biotrend: sample labelling services, 201204– collab supply of Iodine-125 labelling services by Anawa Trading SA 2012-04-30
Analytical Perspectives of North Carolina–SGS: investment, 201204 acquisition 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Malaysia 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Singapore 2012-04-27
Omega Scientific–Ionicon: mass spectrometer, 201204– distribution + support of Ioncion PTR-MS instruments by Omega in Thailand 2012-04-27
Active Biotech–Evotec: drug discovery services, 201204– service €na expansion medicinal chemistry services drug optimisation 2012-04-26
Futalis–High-Tech Gründerfonds: investment, 201204 seed financing from HTGF 2012-04-26
Innovacell–SEVERAL: investment, 201204– capital increase €8.3m in two tranches 2012-04-26
Rhön-Klinikum–Fresenius: investment, 201204–201206 NOT REALISED cash tender offer €3.1b €22.5/share OFFER FAILED 2012-04-26
JnJ–Artes Biotechnology: cell line development, 201204– collab developm + supply of Hansenula cell lines to Crucell for two vaccines 2012-04-24
ConoGenetix–Bavaria (govt): investment, 201204 financing round Series A totalling €1.5m incl returning investor BioM AG 2012-04-23
ConoGenetix–Mey Capital Matrix: investment, 201204 financing round Series A totalling €1.5m incl lead investor Mey Capital Matrix GmbH 2012-04-23
ConoGenetix–SEVERAL: investment, 201204 financing round Series A €1.5m lead investor Mey Capital Matrix + co-investor BioM AG 2012-04-23
AJ Roboscreen–Analytik Jena: investment, 201204 acquisition of remaining shares with resulting 100% ownership by Analytik Jena AG 2012-04-20
4SC–Crelux: drug discovery services, 201204– strategic alliance offering integrated drug discovery services by 4SC Discovery + Crelux 2012-04-18
KonTEM–High-Tech Gründerfonds: investment, 201204 investment by HTGF 2012-04-17
Oncgnostics–High-Tech Gründerfonds: investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Oncgnostics–SEVERAL: investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Oncgnostics–Thuringia (govt): investment, 201204 seed funding from HTGF + STIFT 2012-04-16
Bayer–KWS: plant breeding, 201204– collab co-developm breeding of herbicide-resistant varieties for weed control system Bayer CropScience 2012-04-12
Aleva Neurotherapeutics–SEVERAL: investment, 201204 financing round Series B CHF4m lead + new investor Banexi Ventures Partners 2012-04-10
next pagenext page 1 2 3 ... 41 42 43 ... 53 54 55  next pagenext page


Picture [LSUS] – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top